Neurocrine Biosciences, Inc. (NBIX)
131.43
+1.58
(+1.22%)
USD |
NASDAQ |
Mar 17, 14:30
Neurocrine Biosciences Price : 131.43 for March 17, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Glaukos Corp. | 102.56 |
| Edgewise Therapeutics, Inc. | 30.57 |
| Nuvalent, Inc. | 99.12 |
| Marker Therapeutics, Inc. | 1.37 |
| Agenus, Inc. | 3.84 |
Price Related Metrics
| PE Ratio | 28.16 |
| PS Ratio | 4.706 |
| PEG Ratio | 0.6731 |
| Price to Book Value | 4.055 |
| Price to Free Cash Flow | 17.98 |
| Earnings Yield | 3.55% |
| Market Cap | 13.19B |
| PEGY Ratio | 0.6731 |
| Operating PE Ratio | 21.15 |
| Normalized PE Ratio | 27.31 |